These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4626940)

  • 41. [Preventive value of intravesical thiotepa on the recurrence of Ta-T1 vesical tumors treated by conservative surgery. Apropos of 247 cases a mean follow-up of 88 months].
    Gilloz A; Sauvage I; Gremillet E; Héritier P; Richard A; el Hajj E; Diez-Yanguas J
    J Urol (Paris); 1987; 93(4):197-202. PubMed ID: 3119728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proceedings: Adjuvant intravesical thiotepa and bladder tumour recurrence.
    Boyd PJ; Burnand KG
    Br J Surg; 1975 Feb; 62(2):162. PubMed ID: 803851
    [No Abstract]   [Full Text] [Related]  

  • 43. [Superficial bladder tumors. Preliminary results of a prospective study comparing endovesical BCG, adriamycin and thio-tepa].
    Martínez-Piñeiro JA; de la Peña J; Hidalgo L; Cisneros J; Jiménez León J; Machuca J; Perdices C
    Arch Esp Urol; 1985; 38(6):545-53. PubMed ID: 3938633
    [No Abstract]   [Full Text] [Related]  

  • 44. [Depression of bone marrow after intravesical use of Thio-tepa].
    Malling N
    Ugeskr Laeger; 1980 Sep; 142(40):2630-1. PubMed ID: 6777928
    [No Abstract]   [Full Text] [Related]  

  • 45. [Laryngeal papillomatosis in children. General and local chemotherapy].
    Morgon A; Boulud B
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Feb; 24(2):111-2. PubMed ID: 47902
    [No Abstract]   [Full Text] [Related]  

  • 46. [Local administration of thio-tepa in the prevention of papillomatous neoplasms of the urinary bladder].
    Kaczmarek A
    Wiad Lek; 1977 Feb; 30(3):187-91. PubMed ID: 402747
    [No Abstract]   [Full Text] [Related]  

  • 47. Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.
    Nieh PT; Daly JJ; Irwin RJ; Prout GR
    Invest Urol; 1979 May; 16(6):486-8. PubMed ID: 109416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dibunol and thio-TEPA treatment of bladder tumors].
    Barsel' VA
    Urol Nefrol (Mosk); 1978; (4):27-30. PubMed ID: 98889
    [No Abstract]   [Full Text] [Related]  

  • 49. [Fatal bone marrow aplasia due to endovesical thio-tepa].
    Navas P; Grasset D
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):489-91. PubMed ID: 4216649
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of disseminated breast cancer with triethylen-thiophosphoramide (thio-tepa)].
    Madrigal Alonso PL; Perez Gomez FJ
    Acta Oncol (Madr); 1969; 8(2):135-42. PubMed ID: 4988905
    [No Abstract]   [Full Text] [Related]  

  • 51. Intractable bladder hemorrhage requiring cystectomy after use of intravesical thiotepa.
    Treible DP; Skinner D; Kasimain D; Friedman NB; Kern WH
    Urology; 1987 Dec; 30(6):568-70. PubMed ID: 3120389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride.
    Horn Y; Eidelman A; Walach N; Ilian M
    J Urol; 1981 May; 125(5):652-4. PubMed ID: 6785455
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer.
    Byar D; Blackard C
    Urology; 1977 Dec; 10(6):556-61. PubMed ID: 414402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal failure associated with the use of thio-tepa.
    Schellhammer PF
    J Urol; 1973 Nov; 110(5):498-501. PubMed ID: 4201562
    [No Abstract]   [Full Text] [Related]  

  • 55. Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma.
    Burnand KG; Boyd PJ; Mayo ME; Shuttleworth KE; Lloyd-Davies RW
    Br J Urol; 1976 Feb; 48(1):55-9. PubMed ID: 817761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Use of thiotepa, in local instillation, as a prophylactic treatment for recurrence of superficial tumors of the bladder].
    Toulouse J; Bouffier B; Etievent JP; Bittard M
    J Urol (Paris); 1983; 89(2):85-9. PubMed ID: 6408192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute nonlymphocytic leukemia following bladder instillations with thiotepa.
    Easton DJ; Poon MA
    Can Med Assoc J; 1983 Sep; 129(6):578-9. PubMed ID: 6411320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of superficial bladder tumors in a controlled trial with thio-TEPA versus adriamycin.
    Horn Y; Eidelman A; Walach N; Yuval E; Markowitz A
    J Surg Oncol; 1984 Sep; 27(1):67-9. PubMed ID: 6434883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The harmfulness of intravesical instillations of thiotepa in cases of vesico-renal reflux].
    Rampal M; Alimi JC; Pons G; Fiquet JM
    J Urol Nephrol (Paris); 1978 Mar; 84(3):271-4. PubMed ID: 417193
    [No Abstract]   [Full Text] [Related]  

  • 60. ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumour.
    Masters JR; McDermott BJ; Harland S; Bibby MC; Loadman PM
    Cancer Chemother Pharmacol; 1996; 38(1):59-64. PubMed ID: 8603453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.